Edward Fox from the MS Clinic of Central Texas: Alemtuzumab's Long-Term Studies Show Efficacy for Multiple Sclerosis Treatment

APRIL 19, 2016
Adam Hochron

With a unique delivery method, alemtuzumab (Lemtrada) has proven to be an effective treatment option for multiple sclerosis. While careful monitoring is required, new data has shown benefits for the right patient population.

Edward J. Fox, MD, PhD, director of the MS Clinic of Central Texas, discussed the latest research on Lemtrada, which was presented at the 68th Annual Meeting of the American Academy of Neurology in Vancouver. 

Copyright© MD Magazine 2006-2018 Intellisphere, LLC. All Rights Reserved.